Chippenham-based specialist pharmaceutical firm Vectura has boosted its board with the appointment of two new independent non-executive directors. Jeanne Hecht and Jeanne Thoma took up their roles at the firm, which develops inhalable dry-powder drugs that treat lung conditions such as asthma, emphysema and chronic bronchitis, on December 31. Jeanne Hecht was most recently CEO...